Premier Fund Managers’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,122
Closed -$10.2M 226
2020
Q4
$10.2M Hold
7,122
0.44% 62
2020
Q3
$4.99M Buy
7,122
+660
+10% +$480K 0.29% 88
2020
Q2
$4.52M Buy
+6,462
New +$3.73M 0.28% 82

Other funds holding CDLX

Premier Fund Managers's CDLX Position: Q1 2021 in Review

Premier Fund Managers sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 7,122 shares — an estimated $10.2M sold.

Premier Fund Managers first reported a position in CDLX in Q2 2020 and held it in 3 quarters. The position peaked at $10.2M in Q4 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

  • Premier Fund Managers reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
  • Premier Fund Managers sold 7,122 Cardlytics shares in Q1 2021, an estimated $10.2M.
  • Premier Fund Managers first reported a position in Cardlytics in Q2 2020 and held it in 3 quarters.
  • Premier Fund Managers's Cardlytics position peaked at $10.2M in Q4 2020.
  • 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Premier Fund Managers's 13F filing for Q1 2021, filed 10 May 2021.